Literature DB >> 6401317

Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line.

N Tanigaki, R Tosi, R J Duquesnoy, G B Ferrara.   

Abstract

Three distinct molecular subsets with different structures and alloantigenic determinants were identified in human Ia antigens from cells of an HLA-Dw7 homozygous cell line. The subsets carried DR7 specificity, BR4X7 supertypic specificity and MB2 supertypic specificity, respectively, and were immunospecifically separated by the use of operationally monospecific alloantisera. These specificities showed HLA-linked segregation in families and they were distributed in the population according to different but partially overlapping patterns. On peptide mapping analysis, the three subsets showed marked differences in the beta-chains. The alpha-chains of DR7 and BR4X7 subsets were very similar to each other, whereas the alpha-chains of MB2 subset were distinctive from those of DR7 and BR4X7. These data indicate the presence of a minimum of three HLA-linked loci; DR locus, a locus that encodes BR4X7, and a locus that encodes MB2, and substantiate the three-loci concept for the genetic control of human I antigens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401317      PMCID: PMC2186885          DOI: 10.1084/jem.157.1.231

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay.

Authors:  K Koyama; K Nakamuro; N Tanigaki; D Pressman
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

2.  Identification of an HLA-DR-associated system of B-cell alloantigens.

Authors:  R J Duquesnoy; M Marrari; K Annen
Journal:  Transplant Proc       Date:  1979-12       Impact factor: 1.066

3.  Isolation of glycoproteins from pig lymphocyte plasma membrane using Lens culinaris phytohemagglutinin.

Authors:  M J Hayman; M J Crumpton
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

4.  Purification and separation of subsets of human Ia molecules by papain digestion.

Authors:  N Tanigaki; R Tosi; K Koyama; D Pressman
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

5.  Polymorphism of human B-cell alloantigens: evidence for three loci within the HLA system.

Authors:  M L Markert; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  HLA-DR typing by radioimmunoassay.

Authors:  R Tosi; N Tanigaki; D Centis; P L Rossi; G Alfano; G B Ferrara; D Pressman
Journal:  Transplantation       Date:  1980-04       Impact factor: 4.939

7.  Structural studies on the murine Ia alloantigens. IV. NH2-terminal sequence analysis of allelic products of the I-A and I-E/C subregions.

Authors:  R G Cook; M H Siegelman; J D Capra; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

8.  Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus.

Authors:  N Tanigaki; R Tosi; D Pressman; G B Ferrara
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

9.  HLA-DR antigens have polymorphic light chains and invariant heavy chains as assessed by lysine-containing tryptic peptide analysis.

Authors:  J F Kaufman; R L Andersen; J L Strominger
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

10.  Immunological dissection of human Ia molecules.

Authors:  R Tosi; N Tanigaki; D Centis; G B Ferrara; D Pressman
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  29 in total

1.  Serological discrimination of DR4 haplotypes by radioimmunoassay.

Authors:  N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Southern blot and microfingerprinting analysis of two DR7 haplotypes.

Authors:  G Angelini; N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Subset analysis of human class II molecules controlled by the DR2/Dw2 haplotype: two separate DR subsets carry the DR2 specificity.

Authors:  N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Serological recognition of HLA-DR allodeterminant corresponding to DNA sequence involved in gene conversion.

Authors:  C C Berte; N Tanigaki; R Tosi; J Gorski; B Mach
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

5.  Radioimmunoassay typing gives a more precise definition of the HLA association of type 1 (insulin-dependent) diabetes.

Authors:  R Tosi; M Vela; D Adorno; A Longo; F Papola; D Maccarone; D Centis; N Tanigaki; M P Raponi; A Candela
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

6.  Isolation from human chronic-lymphocytic-leukaemia cells of membrane glycoproteins associated with Fc-receptor functions. Physical parameters and production of polyclonal antibodies.

Authors:  G Gorini; G A Medgyesi; M Garavini; K J Dorrington; J Down
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

7.  Immunochemistry of the HLA class II molecules isolated from a mouse cell transfected with DQ alpha and beta genes from a DR4 haplotype.

Authors:  N Tanigaki; R Tosi; J L Strominger; J Cooper
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

8.  Allelic polymorphism and transassociation of molecules encoded by the HLA-DQ subregion.

Authors:  R C Giles; R DeMars; C C Chang; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci.

Authors:  F Ameglio; M R Capobianchi; A Dolei; R Tosi
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

10.  Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

Authors:  Marcelo A Fernández-Viña; John P Klein; Michael Haagenson; Stephen R Spellman; Claudio Anasetti; Harriet Noreen; Lee Ann Baxter-Lowe; Pedro Cano; Neal Flomenberg; Dennis L Confer; Mary M Horowitz; Machteld Oudshoorn; Effie W Petersdorf; Michelle Setterholm; Richard Champlin; Stephanie J Lee; Marcos de Lima
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.